MTA Angelus

Mineral Trioxide Aggregate · Angelus S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MTA Angelus, covering 2024-11-04 to 2024-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical and Radiographic Evaluation of Hyaluronic Acid (Gengigel Teething) Versus Mineral Trioxide Aggregate( Angelus) as Pulpotomy Agent in Vital Primary Molars [Phase 1]

See pricing